Innospec IOSP Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 27.4%-1.3pp | 27.7%-1.7pp | 28%-2.0pp | 28.4%-2.0pp | 28.7%-2.2pp | |
| Operating margin | 6.9%-2.6pp | 7.3%-2.4pp | 6.9%-2.8pp | 9.1%-0.2pp | 9.5%+0.7pp | |
| Net margin | 6.4%— | 6.6%— | —— | —— | —— | |
| Returns | ||||||
| Return on equity | 8.8%— | 9.2%— | —— | —— | —— | |
| Return on invested capital | 10%-7.3pp | 10.7%-7.5pp | 12%-2.2pp | 15.7%+1.7pp | 17.3%+3.2pp | |
| Efficiency | ||||||
| Asset turnover | 1×0.0× | 1×-0.1× | 1×-0.1× | 1×-0.1× | 1×-0.1× | |
| Liquidity | ||||||
| Current ratio | 3×+0.3× | 2.8×+0.2× | 2.8×+0.2× | 2.9×+0.2× | 2.7×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -1.4×-0.2× | -1.4×-0.3× | -1.3×-0.2× | -1×-0.2× | -1.2×-0.1× | |
| Per Share | ||||||
| Book value per share | $54.14+7.9% | $53.06+10.0% | $52.07+5.1% | $51.73+8.9% | $50.20+6.3% | |
| Valuation | ||||||
| Market capitalization | $1.82B-23.6% | $1.9B-30.9% | $1.92B-32.1% | $2.09B-31.9% | $2.38B-25.8% | |
| Price / earnings | 15.9×— | 16.3×— | —— | —— | —— | |
| Price / sales | 1×-0.3× | 1.1×-0.4× | 1.1×-0.4× | 1.2×-0.5× | 1.3×-0.3× | |
| Price / book | 1.4×-0.5× | 1.4×-0.8× | 1.5×-0.8× | 1.6×-1.0× | 1.9×-0.8× | |
| EV / EBITDA | 9.5×-0.4× | 9.6×-1.7× | 10×-1.4× | 9×-4.1× | 9.9×-4.2× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Innospec's profit margins?
- Innospec (IOSP) runs a 27.4% gross margin and a 6.9% operating margin, with a 6.4% net margin.
- Where do Innospec's ratios come from?
- Every ratio is computed from Innospec's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
